Literature DB >> 25038755

Calcified granulomatous disease: occupational associations and lack of familial aggregation.

Robert M Reed1, Anthony Amoroso, Salman Hashmi, Seth Kligerman, Alan R Shuldiner, Braxton D Mitchell, Giora Netzer.   

Abstract

PURPOSE: The acute host response to histoplasma capsulatum infection varies according to exposure and susceptibility. Late sequelae include calcifications in the lung, thoracic lymphatics, and spleen. Determinants of calcified granuloma formation are poorly studied and may differ from those affecting acute response. We examined the occupational associations and familial aggregation of radiographic calcified granulomatous disease to characterize the determinants of calcified granuloma formation.
METHODS: We analyzed prospectively collected cross-sectional data including computed tomograms from 872 adult members of the Old Order Amish of Lancaster County.
RESULTS: Granulomas were present in 71 % of participants. Granulomas were present in the lung of 57 % of participants, in the hilar or mediastinal lymph nodes of 55 % of participants, and in the spleen of 29 % of participants. No significant differences were observed in the presence of granulomas between men and women. Each year of age was associated with 4 % higher odds of splenic calcifications, and a primary occupation of farming was associated with an 84 % higher odds of splenic calcifications. A compelling pattern of familial aggregation was not observed.
CONCLUSIONS: Calcified granulomatous disease does not appear to aggregate in families. Determinants influencing patterns of granulomatous disease include occupation, age, and geographic location.

Entities:  

Mesh:

Year:  2014        PMID: 25038755      PMCID: PMC4239180          DOI: 10.1007/s00408-014-9624-3

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  31 in total

1.  Abnormal pulmonary granuloma formation in osteopontin-deficient mice.

Authors:  A W O'Regan; J M Hayden; S Body; L Liaw; N Mulligan; M Goetschkes; J S Berman
Journal:  Am J Respir Crit Care Med       Date:  2001-12-15       Impact factor: 21.405

2.  Outbreak of histoplasmosis among employees in a paper factory--Michigan, 1993.

Authors:  M G Stobierski; C J Hospedales; W N Hall; B Robinson-Dunn; D Hoch; D A Sheill
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

Review 3.  Osteopontin: a versatile regulator of inflammation and biomineralization.

Authors:  C M Giachelli; S Steitz
Journal:  Matrix Biol       Date:  2000-12       Impact factor: 11.583

4.  Further observations on histoplasmin sensitivity in the United States.

Authors:  L B Edwards; F A Acquaviva; V T Livesay
Journal:  Am J Epidemiol       Date:  1973-11       Impact factor: 4.897

5.  An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States.

Authors:  L B Edwards; F A Acquaviva; V T Livesay; F W Cross; C E Palmer
Journal:  Am Rev Respir Dis       Date:  1969-04

6.  Intrathoracic calcifications: radiographic features and differential diagnoses.

Authors:  K Brown; D F Mund; D R Aberle; P Batra; D A Young
Journal:  Radiographics       Date:  1994-11       Impact factor: 5.333

Review 7.  The epidemiology of histoplasmosis: a review.

Authors:  M V Cano; R A Hajjeh
Journal:  Semin Respir Infect       Date:  2001-06

8.  Screening for early lung cancer with low-dose spiral CT: prevalence in 817 asymptomatic smokers.

Authors:  Stefan Diederich; Dag Wormanns; Michael Semik; Michael Thomas; Horst Lenzen; Nikolaus Roos; Walter Heindel
Journal:  Radiology       Date:  2002-03       Impact factor: 11.105

Review 9.  Pulmonary histoplasmosis.

Authors:  J W Gurney; D J Conces
Journal:  Radiology       Date:  1996-05       Impact factor: 11.105

10.  Epidemiological survey of histoplasmine and paracoccidioidine skin reactivity in an agricultural area in Bolívar state, Venezuela.

Authors:  Julman Rosiris Cermeño; Isabel Hernández; Julmery Jesús Cermeño; Gerardo Godoy; July Josefina Cermeño; Yida Orellán; Ytalia Blanco; Ismery Cabello; Yesenia Guzmán; Frannelly Alcalá; Teófilo García; Salvador Penna
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.